Ischemic Stroke Clinical Trial
Official title:
Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
Patients presenting to the emergency department with acute ischemic stroke, who are are eligible for standard intravenous thrombolytic therapy within 4.5 hours of stroke onset will be assessed for major vessel occlusion to determine their eligibility for the trial. All participants will receive intravenous tenecteplase and endovascular thrombectomy as standard care. The trial is a Bayesian Optimised Phase 2 dose-finding umbrella trial (single arm versus objective performance criterion of 20% substantial reperfusion prior to endovascular thrombectomy based on the EXTEND-IA TNK trials NCT02388061, NCT03340493). The aim is to determine the optimal dose of intravenous dornase alfa (recombinant human DNase 1) with sufficient promise to take forward in a seamless phase 2b/3 design.
n/a
| NCT number | NCT05203224 |
| Study type | Interventional |
| Source | University of Melbourne |
| Contact | Bruce CV Campbell, MBBS PhD |
| Phone | 0393427000 |
| [email protected] | |
| Status | Not yet recruiting |
| Phase | Phase 2 |
| Start date | February 1, 2022 |
| Completion date | December 31, 2025 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
| Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
| Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
| Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
| Not yet recruiting |
NCT04080791 -
Virtual Reality in Stroke Rehabilitation
|
N/A | |
| Not yet recruiting |
NCT05048004 -
Cerebral Embolization During Pulmonary Vein Isolation
|
||
| Not yet recruiting |
NCT05008588 -
Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05041010 -
Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz
|
Phase 3 | |
| Not yet recruiting |
NCT03684564 -
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
|
Phase 2/Phase 3 | |
| Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
| Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
| Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
| Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
| Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
| Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
| Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A | |
| Completed |
NCT01983644 -
RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study
|
N/A | |
| Completed |
NCT01968122 -
Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China
|
N/A |